Skip to main content
Premium Trial:

Request an Annual Quote

GenScript, Allozymes Partner on Enzyme Discovery and Development Services

NEW YORK – GenScript and Allozymes said on Wednesday that they are partnering on providing services to customers, including enzyme discovery, enzyme development, and protein identification.

Under the terms of the agreement, GenScript will provide mutant synthetic DNA libraries and protein expression while Allozymes will offer high-throughput screening services. Applications will include services for the pharmaceutical, cosmetic, and food and beverage industries.

Financial and other terms of the deal were not disclosed.

"Our relationship with Allozymes spans several years, and we are glad to expand this relationship to be an exclusive partner that provides researchers with a full suite of services, from discovery to expression of target molecules," said Dawn Lee, a sales director at GenScript Asia Pacific.

Singapore-based Allozymes offers droplet microfluidics-based enzyme screening and enzyme development services.

DNA synthesis is one of many services GenScript offers. In September, the firm partnered with Avectas on cell therapy manufacturing and, in April, it entered the DNA-based data storage market.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.